A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.

Blood
M O ArcasoyB G Forget

Abstract

Primary familial erythrocytosis (familial polycythemia) is a rare myeloproliferative disorder with an autosomal dominant mode of inheritance. We studied a new kindred with autosomal dominantly inherited familial erythrocytosis. The molecular basis for the observed phenotype of isolated erythrocytosis is heterozygosity for a novel nonsense mutation affecting codon 399 in exon 8 of the erythropoietin receptor (EPOR) gene, encoding an EpoR peptide that is truncated by 110 amino acids at its C-terminus. The new EPOR gene mutation 5881G>T was found to segregate with isolated erythrocytosis in the affected family and this mutation represents the most extensive EpoR truncation reported to date, associated with familial erythrocytosis. Erythroid progenitors from an affected individual displayed Epo hypersensitivity in in vitro methylcellulose cultures, as indicated by more numerous erythroid burst-forming unit-derived colonies in low Epo concentrations compared to normal controls. Expression of mutant EpoR in interleukin 3-dependent hematopoietic cells was associated with Epo hyperresponsiveness compared to cells expressing wild-type EpoR.

References

May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A de la ChapelleE Juvonen
Mar 6, 1998·British Journal of Haematology·M J PercyT C Pearson
Mar 24, 1999·Current Opinion in Hematology·J F Prchal, J T Prchal
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·V DivokyJ T Prchal
Sep 18, 2001·American Journal of Hematology·R Kralovics, J T Prchal

❮ Previous
Next ❯

Citations

Mar 26, 2011·International Journal of Hematology·Kacey O'RourkeGlen A Kennedy
Nov 26, 2003·Blood Cells, Molecules & Diseases·Katerina JedlickovaJosef T Prchal
Aug 8, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anna BaoutinaKerry R Emslie
Jun 26, 2004·Journal of Pediatric Hematology/oncology·Tom Van MaerkenJoris Verlooy
Feb 14, 2003·Mayo Clinic Proceedings·Ayalew Tefferi
May 15, 2004·British Journal of Haematology·K B PetersenC Guldborg Nyvold
Oct 1, 2008·International Journal of Laboratory Hematology·M F McMullin
Jan 26, 2010·British Journal of Haematology·Lily J HuangGamze B Bulut
Oct 12, 2013·Human Mutation·Celeste BentoUNKNOWN ECE-Consortium
Jun 3, 2011·The Biochemical Journal·Que T LambertGary W Reuther
Jul 25, 2003·Biochemical and Biophysical Research Communications·Murat O ArcasoyZishan A Haroon
Jul 26, 2011·Biochemical Pharmacology·S ChateauvieuxM Diederich
Oct 26, 2010·Biochimica Et Biophysica Acta·G Ferbeyre, R Moriggl
Dec 7, 2018·International Journal of Laboratory Hematology·Danijela VočanecTanja Kunej
May 24, 2006·World Journal of Gastroenterology : WJG·Chun-Lian WangDong-Ye Yang
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrea InthalE Renate Panzer-Grümayer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.